News Conference News TCT 2017 MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months TCT Daily Staff November 06, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017
Presentation TCT 2017 First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR) Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley November 01, 2017